Seung Ick Cha
Overview
Explore the profile of Seung Ick Cha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
772
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim C, Park J, Cha J, Lim J, Park J, Lee Y, et al.
Pleura Peritoneum
. 2024 Jul;
9(2):55-61.
PMID: 38948325
Objectives: The clinical significance of bacteremia in patients with complicated pleural infection is still uncertain. We aimed to examine the incidence and clinical significance of bacteremia in patients with complicated...
2.
Park S, Lim J, Kang M, Park J, Hong C, Kim C, et al.
Radiother Oncol
. 2023 Dec;
192:110053.
PMID: 38104782
Background And Purpose: This study aimed to investigate the predictive factors of severe radiation-induced lung injury (RILI) in patients with lung cancer and coexisting interstitial lung disease (ILD) undergoing conventionally...
3.
Yoo S, Lee S, Choi J, Hong M, Do S, Lee J, et al.
J Korean Med Sci
. 2023 Nov;
38(45):e381.
PMID: 37987107
Background: Neurogenic differentiation 1 (NeuroD1) is a representative small cell lung cancer (SCLC) transcription regulator involved in the carcinogenesis and behavior of SCLC. Histone modifications play an important role in...
4.
Yoo S, Do S, Choi J, Kang H, Hong M, Lee J, et al.
Oncology
. 2023 Aug;
102(1):67-75.
PMID: 37527640
Introduction: Altered lipid metabolism has been reported to be associated with prognosis in multiple cancers. This study aimed to investigate the association of polymorphisms in lipid metabolism pathway genes with...
5.
Lee J, Park J, Hong M, Choi J, Kang H, Do S, et al.
Thorac Cancer
. 2023 Jul;
14(26):2678-2686.
PMID: 37519036
Background: Necroptosis is a regulated inflammatory cell death which plays a significant role in cancer development and progression. In this study, we evaluated whether genetic variants in key regulators of...
6.
Kim C, Park J, Cha J, Park J, Choi S, Seo H, et al.
Medicine (Baltimore)
. 2023 Jun;
102(26):e34134.
PMID: 37390258
Non-expandable lung (NEL) often occurs during pleural fluid drainage in patients with malignant pleural effusion (MPE). However, data regarding the predictors and prognostic impact of NEL on primary lung cancer...
7.
Kim C, Kim H, Park J, Lee Y, Choi S, Seo H, et al.
Tuberculosis (Edinb)
. 2023 Apr;
140:102344.
PMID: 37084568
Limited data exist about the comparative immune cell population profile determined by cytometry by time-of-flight (CyTOF) analysis between active tuberculosis (TB) and latent TB infection (LTBI). In this study, we...
8.
Lee S, Yoo S, Choi J, Hong M, Do S, Lee J, et al.
Thorac Cancer
. 2023 Mar;
14(13):1145-1152.
PMID: 36935366
Background: Neurogenic differentiation factor 1 (NEUROD1) is frequently overexpressed in small-cell lung cancer (SCLC). NEUROD1 plays an important role in promoting malignant behavior and survival. Methods: In this study, we...
9.
Hong M, Park J, Lee S, Lee J, Choi J, Kang H, et al.
J Cancer
. 2023 Jan;
13(15):3701-3709.
PMID: 36606188
Pemetrexed is an anti-folate agent which is one of the most frequently used chemotherapy agents for non-squamous non-small cell lung cancer (NSCLC) patients. However, clinical response to pemetrexed chemotherapy and...
10.
Lee Y, Do S, Lee S, Kang H, Choi J, Hong M, et al.
Oncology
. 2022 Oct;
101(2):96-104.
PMID: 36257285
Objective: This study was conducted to investigate the association between genetic variants in histone modification regions and clinical outcomes of PEM chemotherapy in patients with lung adenocarcinoma. Methods: Potentially functional...